12:00 AM
 | 
Jan 21, 2013
 |  BC Week In Review  |  Company News  |  Deals

Ativa Pharma S.A., Paladin deal

Paladin acquired a controlling stake in specialty pharmaceutical company Ativa on Jan. 1....

Read the full 41 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >